Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 17, Issue 9, 1999, Pages 2692-2699

  Furuse, Kiyoyuki ^a   Fukuoka, Masahiro ^a   Kawahara, Masaaki ^a   Nishikawa, Hideki ^a   Takada, Yoshiki ^a   Kudoh, Shinzoh ^a   Katagami, Nobuyuki ^a   Ariyoshi, Yutaka ^a  

^a OSAKA PREFECTURAL MEDICAL CENTER FOR RESPIRATORY AND ALLERGIC DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOMYCIN; VINDESINE;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; ESOPHAGITIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIMODALITY CANCER THERAPY; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 0032858243     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.9.2692     Document Type: Article

References (22)

1. Pritchard RS, Anthony SP: Chemotherapy plus radiotherapy compared with radiotherapy alone in the treatment of locally advanced, unresectable, non-small cell lung cancer. Ann Intern Med 125:723-729, 1996
2. Le Chevalier T, Arriagada R, Quoix E, et al: Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung cancer: First analysis of a randomized trial in 353 patients. J Natl Cancer Inst 83:417-423, 1991
3. Dillman RO, Seagren SL, Propert KJ, et al: A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small cell lung cancer. N Engl J Med 323.940-945, 1990
4. Schaake-Koning C, Van den Bogaert W, Dalesio O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326:524-630, 1992
5. Non-small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. BMJ 311:899-909, 1995
6. Kubota K, Furuse K, Kawahara M, et al: Role of radiotherapy in combined modality treatment of locally advanced non-small cell lung cancer. J Clin Oncol 12:1547-1552, 1994
7. Furuse K, Kubota K, Kawahara M, et al: Phase II study of concurrent radiotherapy and chemotherapy for unresectable stage III non-small-cell lung cancer: Southern Osaka Lung Cancer Study Group. J Clin Oncol 13:869-875, 1995
8. Mountain C: A new international classification system for lung cancer. Chest 89:225S-233S, 1986 (suppl)
9. World Health Organization: WHO Handbook for Reporting Results of Cancer Treatment. Geneva, Switzerland, WHO offset publication no. 48, 1979
10. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649-655, 1982
11. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
12. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother 50:163-170, 1966
13. 2 tests. Biometrics 10:417-451, 1854
14. Mehta CR, Patel NR: A network algorithm for performing Fisher's exact test in r x c contingency tables. J Am Stat 78:427-434, 1983
15. Mann HB, Whitney DR: On a test of whether one of two random variables is stochastically larger than the other. Ann Math Stat 18:50-60, 1947
16. Truett J, Cornfield J, Kannel W: A multivariate analysis of the risk of coronary heart disease in Framingham. J Chronic Dis 20:511-524, 1967
17. Le Chevalier T, Arriagada R, Tarayre M, et al: Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma. J Natl Cancer Inst 84:58, 1992
18. Sause WT, Scott C, Taylor S, et al: Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small cell lung cancer. J Natl Cancer Inst 87:198-205, 1995
19. Perez CA, Bauer M, Edelstein S, et al: Impact of tumor control on survival in carcinoma of the lung treated with irradiation. Int J Radiat Oncol Biol Phys 12:539-547, 1994
20. Komaki R, Scott C, Ettinger D, et al: Randomized phase II study of chemotherapy/radiation therapy combination for favorable patients with locally advanced inoperable non-small cell lung cancer: Radiation Therapy Oncology Group 92-04. Proc Am Soc Clin Oncol 15:514, 1996 (abstr)
21. Takada M, Fukuoka M, Furuse K, et al: Phase III study of concurrent versus sequential thoracic radiotherapy (TRT) in combination with cisplatin (C) and etoposide (E) for limited-stage (LS) small cell lung cancer (SCLC): Preliminary result of the Japan Clinical Oncology Group. Proc Am Soc Clin Oncol 15:372, 1996 (abstr)
22. Murray N, Coy P, Pater JL, et al: Importance of timing for thoracic irradiation in the combined modality treatment of limited-stage small-cell lung cancer: The National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 11:336-44, 1993